6431 — Kuangli Bio Tech Holdings Co Balance Sheet
0.000.00%
Last trade - 00:00
- TWD678.28m
- TWD1.12bn
- TWD293.37m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 159 | 114 | 183 | 163 | 91 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 266 | 51.8 | 231 | 163 | 136 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 440 | 180 | 523 | 400 | 306 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 14.8 | 22.3 | 382 | 364 | 381 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 555 | 378 | 1,249 | 1,116 | 1,043 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 202 | 56.3 | 328 | 273 | 283 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 203 | 64.2 | 767 | 443 | 485 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 352 | 314 | 482 | 673 | 558 |
Total Liabilities & Shareholders' Equity | 555 | 378 | 1,249 | 1,116 | 1,043 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |